We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
Cap. Flow
-$371M
Cap. Flow %
-2.31%
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$101M
2
ALC icon
Alcon
ALC
+$87.1M
3
OTIS icon
Otis Worldwide
OTIS
+$68.8M
4
MRSH
Marsh
MRSH
+$50M
5
MRK icon
Merck
MRK
+$49.8M

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$56M
2
JPM icon
JPMorgan Chase
JPM
+$42.7M
3
AMZN icon
Amazon
AMZN
+$38.8M
4
AGN
Allergan plc
AGN
+$36.5M
5
MSFT icon
Microsoft
MSFT
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 22.31%
2 Healthcare 14.18%
3 Financials 13.68%
4 Consumer Discretionary 11.52%
5 Communication Services 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEI icon
276
Douglas Emmett
DEI
$1.96B
$9.76M 0.06%
318,311
-3,182
-1% -$95.4K
MKC icon
277
McCormick & Company Non-Voting
MKC
$14.2B
$9.7M 0.06%
108,094
-30,842
-22% -$2.54M
BMRN icon
278
BioMarin Pharmaceuticals
BMRN
$12.4B
$9.68M 0.06%
78,439
-29,308
-27% -$2.91M
TRV icon
279
Travelers Companies
TRV
$80.2B
$9.61M 0.06%
84,283
-5,311
-6% -$560K
RNG icon
280
RingCentral
RNG
$5.28B
$9.59M 0.06%
33,649
-6,091
-15% -$1.54M
BXP icon
281
Boston Properties
BXP
$11.1B
$9.59M 0.06%
106,099
-2,475
-2% -$225K
COF icon
282
Capital One
COF
$134B
$9.42M 0.06%
150,457
-10,288
-6% -$641K
MET icon
283
MetLife
MET
$62.1B
$9.38M 0.06%
256,788
-16,658
-6% -$580K
VRSN icon
284
VeriSign
VRSN
$26.6B
$9.37M 0.06%
45,305
-11,155
-20% -$2.32M
TROW icon
285
T. Rowe Price
TROW
$24.3B
$9.34M 0.06%
75,662
-4,759
-6% -$543K
CERN
286
DELISTED
Cerner Corp
CERN
$9.3M 0.06%
135,731
-32,068
-19% -$2.2M
TFX icon
287
Teleflex
TFX
$5.98B
$9.28M 0.06%
25,483
-10,016
-28% -$3.46M
SGEN
288
DELISTED
Seagen Inc. Common Stock
SGEN
$9.22M 0.06%
54,284
-16,562
-23% -$2.47M
MSCI icon
289
MSCI
MSCI
$40.9B
$9.15M 0.06%
27,419
-1,518
-5% -$491K
AME icon
290
Ametek
AME
$58.2B
$9.14M 0.06%
102,231
-1,338
-1% -$112K
TAL icon
291
TAL Education Group
TAL
$6.87B
$9.11M 0.06%
133,230
-1,940
-1% -$111K
MLM icon
292
Martin Marietta Materials
MLM
$33B
$9.04M 0.06%
43,777
-52,955
-55% -$10.2M
AIG icon
293
American International
AIG
$41.3B
$8.96M 0.06%
287,533
-18,935
-6% -$532K
HR icon
294
Healthcare Realty
HR
$6.84B
$8.96M 0.06%
337,920
-11,666
-3% -$299K
TEL icon
295
TE Connectivity
TEL
$62.6B
$8.95M 0.06%
109,710
-7,055
-6% -$531K
HEI icon
296
HEICO Corp
HEI
$51.4B
$8.91M 0.06%
89,393
-202,313
-69% -$18.7M
KR icon
297
Kroger
KR
$34.8B
$8.8M 0.05%
260,114
-18,939
-7% -$614K
SYY icon
298
Sysco
SYY
$40.3B
$8.77M 0.05%
160,476
-5,488
-3% -$289K
MFC icon
299
Manulife Financial
MFC
$73.5B
$8.75M 0.05%
646,150
-44,291
-6% -$557K
YUM icon
300
Yum! Brands
YUM
$41.1B
$8.72M 0.05%
100,377
-5,947
-6% -$508K

Similar funds

Aviva's Q2 2020 Portfolio in Review

As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
  • Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
  • Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
  • Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
  • Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
  • Aviva opened 49 new positions and closed 36 in Q2 2020.
  • Aviva's portfolio value rose 18% quarter-over-quarter to $16B.

Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.